Immunogenicity and Safety of the M72/AS01 E Candidate Vaccine Against Tuberculosis: A Meta-Analysis

• Published in: Frontiers in immunology Vol. 10; p. 2089
• Main Authors: Ji, Zhenhua, Jian, Miaomiao, Chen, Taigui, Luo, Lisha, Li, Lianbao, Dai, Xiting, Bai, Ruolan, Ding, Zhe, Bi, Yunfeng, Wen, Shiyuan, Zhou, Guozhong, Abi, Manzama-Esso, Liu, Aihua, Bao, Fukai
• Format: Journal Article
• Language: English
• Published: Switzerland 2019
• Subjects: M72/AS01E; vaccine; safety; tuberculosis; immunogenicity

Currently, there is no tuberculosis (TB) vaccine recommended for use in latent TB infections and healthy adults. M72/AS01 is a new peptide vaccine currently under development, which may improve protection against TB disease. This vaccine has been investigated in several phase I/II clinical trials. W...